SQZ Biotechnologies Co CEO Armon Sharei's 2022 pay slips 7% to $2.7M
SQZ Biotechnologies Co reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
SQZ Biotechnologies Co reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, five executives at SQZ Biotechnologies Co received on average a compensation package of $1.4M, a 6% decrease compared to previous year.
Average pay of disclosed executives at SQZ Biotechnologies Co
Armon Sharei, Chief Executive Officer, received $2.7M in total, which decreased by 7% compared to 2021. 68% of Sharei's compensation, or $1.8M, was in option awards. Sharei also received $277K in non-equity incentive plan, $550K in salary, as well as $48K in other compensation.
Howard Bernstein, Chief Executive Officer, received a compensation package of $1.6M, which increased by 21% compared to previous year. 66% of the compensation package, or $1.1M, was in option awards.
Micah Zajic, Chief Financial Officer, earned $1M in 2022, a 32% increase compared to previous year.
Lawrence Knopf, General Counsel, received $944K in 2022, which decreases by 6% compared to 2021.
Marshelle Smith Warren, Chief Medical Officer, earned $776K in 2022.
Related executives
You may also like
Source: SEC filing on April 26, 2023.